Sosei Group Corp. | Mutual Funds
Mutual Funds that own Sosei Group Corp.
JPM Asset JPM The Japan Mother Fund
1,195,200
1.57%
360,004
1.05%
03/26/2018
Legg Mason Funds ICVC - Japan Equity Fund
900,000
1.18%
-180,000
0.94%
07/31/2018
Matthews Asia Growth Fund
682,400
0.9%
0
0.93%
06/29/2018
Alma Capital Invt. Fds. - Eikoh Japan Large Cap Equity
558,800
0.73%
204,800
3.54%
12/31/2017
iShares MSCI EAFE Small Cap ETF
496,000
0.65%
0
0.07%
09/06/2018
iShares Core MSCI EAFE ETF
338,500
0.44%
0
0.01%
09/06/2018
RBC Japanese Equity Fund
252,000
0.33%
52,000
0.39%
12/31/2017
GO UCITS ETF Solutions Plc - DAXglobal Gold Mining Fund
195,976
0.26%
195,976
1.73%
02/28/2018
Candriam Equities L - Biotechnology
160,000
0.21%
0
0.18%
07/31/2018
Canada Pension Plan
156,000
0.21%
20,000
0%
03/31/2018
| Address |
PMO Hanzomon, 11/F
Tokyo Tokyo 102
Japan
|
|
Employees
|
- |
| Website |
http://www.sosei.com |
| Updated |
07/08/2019 |
| Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). Its proprietary StaR (Stabilised Receptor) technology and structure-based drug design (SBDD) platform enables development of drugs for highly validated, yet historically undruggable or challenging GPCRs. The company has multiple programs targeting Alzheimer's disease, schizophrenia, immuno-oncology, migraine, metabolic disease and other rare and specialty indications. |
